Sarcoma after injection of intramuscular iron

Area of Science:

• Oncology
• Pathology
• Toxicology

Background:

• Iron dextran injections are used to treat iron deficiency anemia.
• Injection site reactions can occur with various medical treatments.
• Sarcomata are malignant tumors of connective tissue.

Purpose of the Study:

• To report cases of sarcoma developing after iron dextran administration.
• To investigate the potential link between iron dextran and sarcoma formation.
• To compare histological findings with animal study data.

Main Methods:

• Case report presentation.
• Histopathological examination of tumor tissue.
• Review of patient history for iron dextran exposure.

Main Results:

• Two patients developed sarcomata at prior iron dextran injection sites.
• One sarcoma displayed a specific histological pattern associated with iron dextran in animal models.
• No other common etiological factors for sarcoma were identified.

Conclusions:

• Iron dextran administration may be a risk factor for sarcoma development.
• Further research is warranted to confirm the carcinogenicity of iron dextran.
• Histological analysis can provide clues to treatment-related tumorigenesis.